Faedda R - Search Results

1

Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature.

Erre GL, Pardini S, Faedda R, Passiu G. Erre GL, et al. Among authors: faedda r. Lupus. 2008 Jan;17(1):50-5. doi: 10.1177/0961203307085251. Lupus. 2008. PMID: 18089684 Review.

2

Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis.

Erre GL, De Muro P, Dellacà P, Fenu P, Cherchi GM, Faedda R, Passiu G. Erre GL, et al. Among authors: faedda r. Clin Exp Rheumatol. 2008 Nov-Dec;26(6):1095-8. Clin Exp Rheumatol. 2008. PMID: 19210877 Clinical Trial.

3

The "sclerodermic hand": a radiological and clinical study.

Erre GL, Marongiu A, Fenu P, Faedda R, Masala A, Sanna M, Soro G, Tocco A, Piu D, Marotto D, Passiu G. Erre GL, et al. Among authors: faedda r. Joint Bone Spine. 2008 Jul;75(4):426-31. doi: 10.1016/j.jbspin.2007.07.017. Epub 2008 May 2. Joint Bone Spine. 2008. PMID: 18455947

4

[Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis].

Erre GL, Tocco A, Faedda R, Cossu A, Carcassi A. Erre GL, et al. Among authors: faedda r. Reumatismo. 2004 Apr-Jun;56(2):118-23. doi: 10.4081/reumatismo.2004.118. Reumatismo. 2004. PMID: 15309221 Free article. Italian.

5

Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.

Erre GL, Bosincu L, Faedda R, Fenu P, Masala A, Sanna M, Taras L, Longu MG, Piras M, Soro G, Satta AE, Passiu G. Erre GL, et al. Among authors: faedda r. Rheumatol Int. 2014 Apr;34(4):535-41. doi: 10.1007/s00296-013-2900-3. Rheumatol Int. 2014. PMID: 24232504

6

Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.

Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E. Faedda R, et al. Clin Nephrol. 1996 Oct;46(4):237-44. Clin Nephrol. 1996. PMID: 8905208

7

Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome.

Pirisi M, Faedda R, Satta A, Bartoli E. Pirisi M, et al. Among authors: faedda r. Clin Drug Investig. 1998;16(3):211-8. doi: 10.2165/00044011-199816030-00005. Clin Drug Investig. 1998. PMID: 18370542

8

Regression of Henoch-Schönlein disease with intensive immunosuppressive treatment.

Faedda R, Pirisi M, Satta A, Bosincu L, Bartoli E. Faedda R, et al. Clin Pharmacol Ther. 1996 Nov;60(5):576-81. doi: 10.1016/S0009-9236(96)90154-X. Clin Pharmacol Ther. 1996. PMID: 8941031

9

Immunosuppressive treatment of Berger's disease.

Faedda R, Pirisi M, Satta A, Bosincu L, Bartoli E. Faedda R, et al. Clin Pharmacol Ther. 1996 Nov;60(5):561-7. doi: 10.1016/S0009-9236(96)90152-6. Clin Pharmacol Ther. 1996. PMID: 8941029

10

Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor α in active and quiescent systemic lupus erythematosus.

Cigni A, Pileri PV, Faedda R, Gallo P, Sini A, Satta AE, Marras R, Carta E, Argiolas D, Rum I, Masala A. Cigni A, et al. Among authors: faedda r. J Investig Med. 2014 Jun;62(5):825-9. doi: 10.2310/JIM.0000000000000085. J Investig Med. 2014. PMID: 24987977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters